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Mitochondria represent the key site for using and delivering energy for any cell in metabolically active tissues or organs 
such as skeletal muscles, heart, brain, and kidney. Proper nutrition, and in particular caloric restriction imitation, is a 
fundamental tool to retard aging, being able to stimulate mitochondria biogenesis and function. In an attempt to limit 
progressive organ dysfunctions associated with aging and metabolic disorders, we adopted a nutritional strategy based on 
the long-term supplementation to rodents of a balanced branched-chain amino acid mixture. Moreover, we tested taurine, a 
non essential beta-amino acid dissolved in drinking water for two weeks, in rats given puromycin aminonucleoside to 
reproduce podocyte damage and proteinuria. Here we resume our main morphological findings obtained by light and 
ultrastructural analysis and morphometry on mitochondria, associated with fibrosis and nitrosactive stress. All experiments 
revealed the effectiveness of amino acids supplementation to improve mitochondria feature and to reduce nephrosis, 
suggesting that a diet based on a single amino acid or better a mixture, may represent a promising anti-aging strategy also 
for humans. 
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1. General remarks 
Aging induces progressive organ malfunctions and chronic diseases (including atherosclerosis, cancer, diabetes, 
sarcopenia) that have a large impact on social and sanitary costs all over in the world, so preventive anti-aging strategies 
represent a crucial issue [1].  
 A key event that characterizes aging is the change in metabolism and the abnormal balance between anabolic and 
enhanced catabolic activities, which lead to inability to fulfill basal energetic requirements in fundamental organs like 
heart, skeletal muscles, brain [2, 3]. Mitochondria are the favourite centre of aerobic metabolism necessary to produce a 
large amount of energy, associated to adenosine triphosphate molecule (ATP) via the oxidative phosphorylation 
reaction [4]. This biochemical reaction is responsible for converting energy from several macronutrients, like amino 
acids or carbohydrates to ATP molecule, through a sequence of mitochondrial reactions, called “the respiratory chain”, 
that end with the reduction to water and adenosine diphosphate (ADP) phosphorylated to ATP [5]. 
It is accepted that aging is also “a mitochondrial affair”, linked to a less amount of vital and efficient mitochondria in  
organs that develop a metabolic impairment and inability to respond properly to whole organism demands [6, 7]. 
Mitochondria morphology varies with aging and structural mitochondrial alterations are involved in several key 
pathologies associated with aging [8]. Indeed the crucial importance of mitochondria in the longevity of cells is 
strengthened by the evidence that mitochondria are not static organelles but they change their shape and density by 
using fusion and/or fission of their intrinsic DNA (mtDNA) [9, 10, 11]. Short and long-term mitochondrial dysfunctions 
and altered mitochondria size and density have been detected after oxidative damage and in aged organs in rodents [12, 
13, 14].   
 During senescence the major deposition of reactive oxygen species (ROS) progressively damage mitochondria by 
replacing normal mtDNA with altered mtDNA, in the so called “free radical theory of aging” [15, 16]. Proteomic 
studies on mitochondria have recently characterized many genes, transcription factors and proteins like sirtuins, 
specifically associated to mitochondria activity during aging [17, 18, 19]. In this article we wish to remark that, beside 
molecular approach, also microscopy has a crucial role in the basic and clinical research on mitochondriopathies and 
aging-associated disorders. In fact any morphological approach on mitochondria may reliably report on the energy-
providing system in that organism [20]. 
 Malnutrition and micronutrient paucity, frequent in senescence, selectively impair mitochondria structure and 
metabolism, and vitamins, minerals or proteins deficit often induces oxidative stress, mtDNA damage and irreversible 
mitochondria decay [21, 22]. In this scenario, a preventive and therapeutical nutritional approach may be necessary to 
retard the onset of aging-related diseases and in particular to preserve mitochondria feature and activity. 
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2. Caloric restriction and aging 
Caloric restriction (CR), without malnutrition, represents one of the most effective tools to maintain mitochondria 
health and the proper energetic supply, so extending the life-span in different organisms [23-26].  
People practicing CR introduce generally 20%-30% fewer calories than recommended, while they eat a nutrient dense 
diet to fulfill all adequate nutritional requirements [27-28]. So it is important to remark that CR does not mean 
necessary dietary restriction, but a suitable caloric intake. 
 There are several described methods to obtain CR aimed to achieve longevity, including alternate day fasting, or 
associate caloric restriction and expending energy with physical exercise, or restriction of specific groups of food [29]. 
Recent evidence suggests that CR and a reduction of glucose metabolism are able to extend the life-span in various 
lower organisms such as Drosophila melanogaster and Caenobarbitis elegans, by promoting controlled release of ROS 
and consequently an adaptive  mitochondria hormesis or mitohormesis [30]. Therefore, according to this different 
perspective, CR causes a regulatory response to specific metabolic alterations during food deprivation or reduced food 
uptake [31]. Until recently ROS or nitrogen reactive species were considered to be toxic products of aerobic energetic 
metabolism in cells; nevertheless, there are increasing indications that experimental amplification of anti-oxidant 
defenses obtained by controlled oxidative stress might enhance the resistance to unavoidable deterioration linked to 
aging. The redox-state of cells and mitochondria integrity are the inner sensors that trigger aging-associated 
dysfunctions [32]. 
 Although CR has beneficial modulatory effects and is able to stimulate mitochondria biogenesis in different animal 
models and humans [33], such nutritional regimen is hardly useful in the senescent people.  
 Indeed CR should be prolonged for long time (at least over 6 months) and this schedule is difficult to be followed in 
the elderly [34]. Thus, different research groups are working to resolve this problem by testing alternative formulations 
able to mimic CR with dietary limitation but no reduction in caloric intake, but the results are not convincing yet [35, 
36].  
 In particular resveratrol, a plant-derived polyphenol present in grapes, or rapamycin, an immunosuppressive 
antibiotic, have been variably tested as promising anti-aging dietary supplements in rodents even if their real efficacy in 
humans is questionable [37, 38]. Other drugs that reduce insulin and circulating glucose, like metformin and a non-
metabolizable glucose analogue, 2-deoxyglucose, have been proposed as potential CR inducing agents. However, the 
proper dose able to sustain a positive effect is variable in different organisms and, unfortunately, it results often toxic in 
rats [39].  
 Epigenetic mechanisms have been  recently considered potential contributors to nutritional control of aging and 
longevity. In particular DNA methylation and chromatin modifications may influence the life-span [40]. CR stimulates 
specific genes called “vitagenes” that, recognizing the intracellular nutrient status and the functional mitochondria, 
encode for homeostatic stress proteins and thioredoxin system [41]. Finally CR directly stimulates mitochondria 
bioenergetics and longevity by interacting with regulatory pathways based on sirtuins and  heat shock proteins [42, 43, 
44, 45]. 
 In Fig. 1 we summarize the impact of oxidant damage, associated with aging and life styles, on mitochondria quality 
control pathways. 
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Fig.1 Consequences of aging and life style on mitochondria biogenesis, number and integrity. (ROS = reactive oxygen species; CR = 
caloric restriction; Mt = mitochondria; large arrows down = decrease; large arrows up = increase; ┴ = inhibition) 
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3. Amino acid mixture and aging 
In eukaryotic organisms energy metabolism is sustained by a strict network of regulatory molecules, hormones, 
metabolites and nutrients that control both anabolic and catabolic pathways. Among all these controllers, dietary amino 
acids have been considered mainly anabolic effectors. Indeed, amino acids are the building blocks for the synthesis of  
structural proteins and other fundamental bioactive molecules, which include neurotransmitters (serotonin, dopamine, 
GABA), hormones (epinephrine, thyroxine), antioxidants (glutathione, melatonin). Several dietary regimens based on 
amino acid mixtures were demonstrated to improve metabolism by restoring altered protein content in damaged tissues 
like atrophic skeletal muscles in aged people [46, 47]. A recent nutritional study conducted on old rodents has 
demonstrated that increased splanchnic sequestration of amino acid during meals induced the paucity of net whole-body 
proteins synthesis and so sarcopenia that occurred during aging [48]. 
 Traditionally amino acids have been classified as essential (EAA) or non essential (NEAA). EAA are called 
indispensable because their carbon skeletons must be provided only from an adequate nutrition, whereas NEAA are 
synthesized in a species-dependent manner, so dietary intake is not so necessary [49]. Actually nutritional indication on 
the use of NEAA in human diet requirements is still lacking [50]. Nevertheless the nutritional strategy that uses amino 
acids in the treatment of aging and age-related diseases is based  on  the human necessity to introduce a constant and 
adequate nitrogen supplementation for general metabolism [51]. Considering that in advanced protein diets is crucial 
the introduction of  “functional amino acids”, i.e. amino acids like glutamine and arginine, able to properly stimulate 
specific metabolic pathways and ensure growing, health and reproduction in organisms [52], we dedicated many 
experimental studies to this topic. 
 In particular, we orally supplemented rodents with a balanced EAA mixture, able to provide 1.5 g/Kg/day amino 
acids contributing 6 kcal/kg/day, in drinking water for two or three months. Along with prolonged survival, enhanced 
mitochondrial biogenesis and amelioration in the morphology of both skeletal muscles and cardiomyocytes were 
observed [53, 54, 55]. Since functional mitochondria alterations and changes in their dynamic nature are still difficult to 
be visualized in vivo, we performed high resolution transmission electron microscopy (TEM), associated to 
morphometry, to describe and quantify aging changes in skeletal muscles and in the heart. Following EAA intake, we 
detected in aged quadriceps muscle both an increasing number of mitochondria and the presence of small size-
mitochondria (about 43%), probably as consequence of biogenesis or due to the fission of pre-existing mitochondria. In 
the aged mice heart, we observed normal mitochondria and an increased density (about 40%), while cristae organization 
was regular and giant mitochondria, a hallmark of aging, absent after EAA supplementation (Fig. 2).  
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Fig.2 A) Density of mitochondria in heart and skeletal muscle according to groups. Aged animal show significant reduction of 
mitochondria density compared to adult ones. On the contrary, the mitochondria density in aged EAA fed animals is higher than aged 
group and similar to those observed in adult animals in both heart and skeletal muscle samples; * p<0.05 vs adult; ° p<0.05 vs aged. 
B-C) TEM micrographs showing heart mitochondria in aged (B) and aged EEA fed animals (C). The aged animals show fewer and 
smallest mitochondria, whereas the mitochondria of EEA fed animals appear to be larger and numerous than aged (Scale bar 20μm).  
 
 Considerable amelioration of fibrosis and less collagen deposition after EAA mixture supplementation were  further 
demonstrated in muscles and heart by correlative light microscopy using  Sirius red method (Fig. 3).  
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Fig. 3 A) Fibrosis degree in heart and skeletal muscle according to groups represented as Integrated Optical Density (IOD). The EAA 
supplementation of aged animals reduces significantly the fibrosis degree similarly to adult ones in both heart and skeletal muscle * 
p<0.05 vs adult; ° p<0.05 vs aged. B-D) light micrographs taken by  polarized light from heart showing the fibrosis in each groups. 
The aged plus EEA fed animals show very scarce fibrosis compared to aged ones (scale bar 20μm). 
 
 We remarked that the efficacy of EAA supplementation on mitochondria rejuvenation is organ specific, not 
beneficial in the liver and adipose tissue, and particularly beneficial in middle-age rodents that increased their average  
life-span  [56]. If EAA addition stimulates organ-specific mitochondrial biogenesis and recovery, it may be useful and 
promising as adjuvant to maintain or prolong wellness in middle-age, so retarding unavoidable senescence. 
Besides direct mitochondria observation and quantification, microscopy is helpful in indirect assessment of 
mitochondria physiology by visualization of selected enzymatic activities in tissues [57] and the expression of specific 
mitochondrial markers like chaperones HSP60 and GRP75 [58].   
 In middle-aged rat kidney we demonstrated that EAA supply potentiates chaperones immunostaining with respect to 
rodent fed normal diet [59]. The strengthening of chaperone activity is a crucial anti-aging strategy that makes  
mitochondria similar to juvenile conditions, so more able to react against ROS attacks. Indeed, mitochondrial 
chaperones are crucial in the proper folding and activity of respiratory chain enzymes, they are also able to mediate 
calcium flux inside mitochondria and represent the main sensor of oxidative stress [60]. Furthermore, inside 
mitochondria the activity of complex IV or cytochrome c oxidase (COX) is easily detectable by histochemistry. 
Considering that the catalytic subunits of COX are selectively encoded by mtDNA and are necessary for proper  
complex assembly, COX  histochemistry is the gold standard method to indicate proper mitochondria status and 
changes during oxidative damage [12].  
 Moreover in the kidney the production of nitric oxide (NO) by different nitric oxide synthase isoforms may 
significantly influence hemodynamic and  hypertension [61]. In our in vivo model we observed enhanced endothelial 
nitric oxide synthase (eNOS) in renal tubules in middle-aged rats after EAA supplementation, similar to younger rats 
and this finding well correlated with enhanced mitochondria biogenesis [62]. To strengthen the utility of  long term 
EAA diet, we showed  COX trend and eNOS immunostaining in the kidney of middle-aged (M-aged, 9 months old) rats 
plus or without supplementation compared with adult (4 months old) rats (Fig. 4). 
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Fig.4 A) Integrated optical density (IOD) of COX and eNOS in kidney according to groups. The EAA supplementation in middle-
aged (M-aged) animals restores the COX and eNOS expression similarly to those observed in adult ones. * p<0.05 vs adult; ° p<0.05 
vs aged. B-D) eNOS immunostaining in kidney according to groups. The M-aged+EEA fed animals show evident immunostaining 
like as adult ones (scale bar 20μm). 
 
   The results obtained indicated directly or indirectly  mitochondrial rejuvenation after three months EAA intake and 
may be promising to suggest the prolonged use of specific nutrients in the prevention of aging-associated degenerative 
changes.  
4. Taurine intake in puromycin aminonucleoside (PAN) nephrosis 
Another nutritional rodent model described here is the introduction of the amino acid taurine, ad libitum via drinking 
water for two weeks, to rats presenting proteinuria and nephrosis induced by PAN, an adenosine derivative used as an 
antibiotic and anti-proliferative drug in humans [63]. The rationale of this study  is due to our  current interest in 
nutrition and  previous experience in drugs inducing renal toxicity assessed in vivo and in vitro models [64, 65]. 
Taurine (TAU), known also as 2-aminoethanesulfonic acid, is a non-essential beta amino acid, which has many 
pleiotropic activities: it is not incorporated in proteins but works like a potent free radicals scavenger and osmo-
regulator agent and prevents DNA damage at physiological concentrations [66-67].  
TAU is present at high concentration in many organs like heart, brain, liver where it derives from others amino acids 
like methionine or cysteine [68].   
 Moreover it protects cellular membranes against oxidative damage and ischemia/reperfusion injury [69]. In the past, 
TAU has been successfully tested in rodents against chronic renal diseases such as streptozocin-induced diabetes, toxic 
nephropathies and hypertension [70, 71, 72].  
The most used animal model to study nephrotic syndrome, and podocyte damage is PAN-injection in rats, whereas mice 
are generally adopted as transgenic models to study gene silencing [73, 74].  
 Recently it has been proposed to classify  podocytopathies  into four categories on the basis of the glomerular 
morphology and podocytes preservation: 1) minimal change disease (where podocyte number was unaffected); 2) focal 
segmental glomerulosclerosis; 3) mesangial sclerosis; 4) capillary collapse (high podocyte proliferation) [75]. 
A significant amount of our current knowledge on  minimal change (MC) disease  has come from experimental studies 
in rats injected with PAN, that develop podocyte foot effacement and loss of  the electronegative charge of the 
glomerular barrier and reversible proteinuria [76]. 
 It is necessary to remind  that glomerular ultra-filtration barrier consists of three layers, starting from the blood flux: 
the endothelium with pores, the glomerular basement membrane and the visceral epithelial podocytes [77]. In particular 
podocytes represent a fundamental component of glomerular barrier, particularly vulnerable to injury: indeed they are  
high differentiated post-mitotic cells, similar to neurons, and unable to proliferate. Remarkably they do not restore after 
a severe stress and so glomerular filtration irreparably changes [78].  
 A recent wave of research indicates that quiescent post-mitotic podocytes undergo a metabolic dysfunction and in 
particularly mitochondrial deficit during experimental nephrosis and podocyte damage induced by aldosterone [79-80]. 
Indeed in humans, MC nephrosis, that affects mainly children, is generally treated by corticosteroids, which have 
adverse side-effects in long term schedule.  
 According to innovative studies by Clement [81] and Reisen [82], a new avenue to study the pathogenesis of MC 
nephrosis and its treatment is directed to abnormal podocytes that secrete a diffusible glycoprotein, called angiopoietin-
like-4 (ANGPTL4), hyposialylated in the blood.  
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 Feeding rats with sialic acid precursors may increase ANGPTL4 sialylation and reduce proteinuria. A nutritional 
strategy with acid sialyc precursors, like N-acetyl-D-mannosamine, indicates an alternative way in the treatment of 
proteinuria linked to acquired MC disease. So novel nutritional strategies based on major sialylation, may alleviate the 
necessity to introduce large amount of steroids in organisms or even eliminate their necessity. 
  Other dietetic strategies based on antioxidants, like grape seed extract and  vitamins, have been  reported to 
ameliorate MC nephrosis and to prevent its progression  into irreversible  focal segmental glomerulosclerosis [83, 84]. 
If proteins inside the basement membrane of podocytes are directly involved in the charges distribution and selective 
transfer of elements from the blood, the continuous flux of materials requires  metabolically active  and efficient 
podocytes [85, 86].  
 Previous studies reported that podocytes hypertrophy and glomerular  fibrosis in aging are ameliorated by caloric 
restriction in rats [87]. Morphological and molecular studies outline that  it is essential to preserve mitochondria in 
podocytes for limiting the progression of acquired MC disease into unavoidable renal impairment [88, 89].   
Indeed podocyte health has been considered not only a “morphologic” but also a “metabolic affair”, linked to many 
energy-consuming processes and therefore to the proper function of mitochondria, lysosomes and endoplasmic 
reticulum  [90, 91]. 
 To achieve this metabolic effect we tested TAU (1.5% in drinking water) one week before PAN (15 mg/hg)  i.p. 
injected in  adult rats and again another week after the antibiotic challenge. Proteinuria, measured by commercial kit in 
24h collected urine, was significantly ameliorated by TAU administration versus PAN group together with 
mitochondrial chaperones expression  within glomeruli. Among  stress proteins analyzed, we focus here on mortalin/mt 
Hsp70/Grp75, a chaperone essential for delivery of mitochondrial enzymes, and strongly involved in the apoptotic 
response via the p53 regulation in nephrotoxic models [92]. Grp75 is down-regulated in aging kidney and in mercury 
nephropathy and influenced by nutritional antioxidant strategies [58, 63]. In Fig.5 we show microscopic feature of  
Grp75 immunolocalization in the rat glomerulus after TAU alone, PAN or combined PAN plus TAU regimens.  
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Fig.5 Grp75 immunolocalization in the rat glomerulus according to groups. (A) TAU administration did not vary significantly the 
immunostaining compared to saline group (D). On the contrary PAN administration increased strongly the chaperone 
immunostaining (B). TAU administration in PAN treated animals attenuated significantly the chaperone signal (C), suggesting a 
protective role of TAU against oxidant damage. Scale bar 20μm 
 
 Remarkably in animals drinking TAU or normal tap water, used as control group, we observed almost similar weak 
brown reaction in the glomerular filter, while in contrast, after a single PAN injection, Grp75 staining significantly 
enhanced in the glomerulus. Finally after TAU plus PAN supplementation, the overall distribution of Grp75 was similar 
to controls. These findings might indicate that  intense Grp75 is necessary to counteract ROS and oxidant damage 
induced by PAN [93] and probably pro-apoptotic changes as reported previously by Pedreanez et al. [94]. On the 
contrary, attenuated glomerular Grp75 signal indicates that the glomerular metabolism is not  damaged anymore. 
Nevertheless it is important to outline that TAU is effective here on mitochondria probably as ROS scavenger because it 
is known that this beta-amino acid, devoid of a carboxyl group, is absent from cellular proteins and does not represent a 
direct source of energy.  
 In conclusion, a diet based on a specific amino acid alone or in a mixture may retain mitochondria rejuvenation in 
different experimental conditions and we believe that correlative light and electron microscopy based on histochemical, 
immunohistochemical and ultrastructural analyses play an important role in the modern nutritional research.  
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